Tamashiro Tami T, Dalgard Clifton Lee, Byrnes Kimberly R
Neuroscience Program, Uniformed Services University, USA.
J Vis Exp. 2012 Aug 15(66):e3814. doi: 10.3791/3814.
Microglia account for approximately 12% of the total cellular population in the mammalian brain. While neurons and astrocytes are considered the major cell types of the nervous system, microglia play a significant role in normal brain physiology by monitoring tissue for debris and pathogens and maintaining homeostasis in the parenchyma via phagocytic activity. Microglia are activated during a number of injury and disease conditions, including neurodegenerative disease, traumatic brain injury, and nervous system infection. Under these activating conditions, microglia increase their phagocytic activity, undergo morpohological and proliferative change, and actively secrete reactive oxygen and nitrogen species, pro-inflammatory chemokines and cytokines, often activating a paracrine or autocrine loop. As these microglial responses contribute to disease pathogenesis in neurological conditions, research focused on microglia is warranted. Due to the cellular heterogeneity of the brain, it is technically difficult to obtain sufficient microglial sample material with high purity during in vivo experiments. Current research on the neuroprotective and neurotoxic functions of microglia require a routine technical method to consistently generate pure and healthy microglia with sufficient yield for study. We present, in text and video, a protocol to isolate pure primary microglia from mixed glia cultures for a variety of downstream applications. Briefly, this technique utilizes dissociated brain tissue from neonatal rat pups to produce mixed glial cell cultures. After the mixed glial cultures reach confluency, primary microglia are mechanically isolated from the culture by a brief duration of shaking. The microglia are then plated at high purity for experimental study. The principle and protocol of this methodology have been described in the literature. Additionally, alternate methodologies to isolate primary microglia are well described. Homogenized brain tissue may be separated by density gradient centrifugation to yield primary microglia. However, the centrifugation is of moderate length (45 min) and may cause cellular damage and activation, as well as, cause enriched microglia and other cellular populations. Another protocol has been utilized to isolate primary microglia in a variety of organisms by prolonged (16 hr) shaking while in culture. After shaking, the media supernatant is centrifuged to isolate microglia. This longer two-step isolation method may also perturb microglial function and activation. We chiefly utilize the following microglia isolation protocol in our laboratory for a number of reasons: (1) primary microglia simulate in vivo biology more faithfully than immortalized rodent microglia cell lines, (2) nominal mechanical disruption minimizes potential cellular dysfunction or activation, and (3) sufficient yield can be obtained without passage of the mixed glial cell cultures. It is important to note that this protocol uses brain tissue from neonatal rat pups to isolate microglia and that using older rats to isolate microglia can significantly impact the yield, activation status, and functional properties of isolated microglia. There is evidence that aging is linked with microglia dysfunction, increased neuroinflammation and neurodegenerative pathologies, so previous studies have used ex vivo adult microglia to better understand the role of microglia in neurodegenerative diseases where aging is important parameter. However, ex vivo microglia cannot be kept in culture for prolonged periods of time. Therefore, while this protocol extends the life of primary microglia in culture, it should be noted that the microglia behave differently from adult microglia and in vitro studies should be carefully considered when translated to an in vivo setting.
小胶质细胞约占哺乳动物大脑细胞总数的12%。虽然神经元和星形胶质细胞被认为是神经系统的主要细胞类型,但小胶质细胞在正常脑生理学中发挥着重要作用,通过监测组织中的碎片和病原体,并通过吞噬活动维持实质内的稳态。在许多损伤和疾病状态下,包括神经退行性疾病、创伤性脑损伤和神经系统感染,小胶质细胞会被激活。在这些激活条件下,小胶质细胞增加其吞噬活性,经历形态和增殖变化,并积极分泌活性氧和氮物种、促炎趋化因子和细胞因子,常常激活旁分泌或自分泌回路。由于这些小胶质细胞反应在神经疾病的发病机制中起作用,因此专注于小胶质细胞的研究是必要的。由于大脑的细胞异质性,在体内实验中技术上难以获得足够高纯度的小胶质细胞样本材料。目前关于小胶质细胞神经保护和神经毒性功能的研究需要一种常规技术方法,以持续产生足够数量的纯净且健康的小胶质细胞用于研究。我们以文字和视频形式展示了一种从混合胶质细胞培养物中分离纯原代小胶质细胞的方案,用于各种下游应用。简而言之,该技术利用新生大鼠幼崽的解离脑组织来产生混合胶质细胞培养物。当混合胶质细胞培养物达到汇合状态后,通过短暂摇晃从培养物中机械分离出原代小胶质细胞。然后将小胶质细胞以高纯度接种用于实验研究。该方法的原理和方案已在文献中有所描述。此外,分离原代小胶质细胞的替代方法也有详细描述。匀浆后的脑组织可通过密度梯度离心分离以获得原代小胶质细胞。然而,离心时间适中(45分钟),可能会导致细胞损伤和激活,以及使小胶质细胞和其他细胞群体富集。另一种方案已被用于通过在培养过程中长时间(16小时)摇晃来分离多种生物体中的原代小胶质细胞。摇晃后,将培养基上清液离心以分离小胶质细胞。这种较长的两步分离方法也可能扰乱小胶质细胞的功能和激活。我们实验室主要采用以下小胶质细胞分离方案有多个原因:(1)原代小胶质细胞比永生化啮齿动物小胶质细胞系更忠实地模拟体内生物学;(2)名义上的机械破坏使潜在的细胞功能障碍或激活最小化;(3)无需传代混合胶质细胞培养物即可获得足够的产量。需要注意的是,该方案使用新生大鼠幼崽的脑组织来分离小胶质细胞,而使用成年大鼠分离小胶质细胞会显著影响分离出的小胶质细胞的产量、激活状态和功能特性。有证据表明衰老与小胶质细胞功能障碍、神经炎症增加和神经退行性病变有关,因此先前的研究使用离体成年小胶质细胞来更好地理解小胶质细胞在神经退行性疾病中的作用,其中衰老为重要参数。然而,离体小胶质细胞不能长时间保存在培养中。因此,虽然该方案延长了培养中原代小胶质细胞的寿命,但应注意小胶质细胞的行为与成年小胶质细胞不同,在转化为体内情况时应仔细考虑体外研究。